Table 2.
Clinical characteristics | No-severe (n = 89) | Severe (n = 62) | P |
---|---|---|---|
Age, mean ± SD, y | 61.8 ±13.8 | 64.0 ± 13.9 | 0.17 |
Female/Male | 50/39 | 30/32 | 0.35 |
Highest temperature mean ± SD, °C |
38.0 ± 0.9 | 38.3 ± 0.9 | 0.02 |
Course of disease, mean ± SD, days | 17.2 ± 10.9 | 20.1 ± 10.1 | <0.05 |
Initial symptoms | |||
Fever | 54 | 41 | 0.49 |
Cough | 48 | 30 | 0.50 |
Dyspnea | 27 | 21 | 0.65 |
Fatigue or myalgia | 19 | 14 | 1.00 |
Digestive symptoms | 6 | 1 | 0.14 |
Therapy | |||
Antiviral | 54 | 42 | 0.37 |
Antibiotic | 34 | 37 | 0.009 |
Antioxidant | 17 | 17 | 0.23 |
Hormone | 7 | 17 | 0.001 |
Resochin | 9 | 5 | 0.67 |
Clinical outcomes | |||
ARDS | 5 | 17 | 0.002 |
ICU admission | 3 | 18 | <0.01 |
Discharged | 50 | 6 | <0.01 |
Died | 1 | 4 | <0.01 |
Hospitalization | 38 | 52 | <0.01 |
ICU, intensive care unit; ARDS, acute respiratory distress syndrome.